(Press-News.org) Contact information: Jim Fessenden
james.fessenden@umassmed.edu
508-856-2000
University of Massachusetts Medical School
2 genetic wrongs make a biochemical right
Genetic mutation found to restore translational balance in mice
WORCESTER, MA – In a biological quirk that promises to provide researchers with a new approach for studying and potentially treating Fragile X syndrome, scientists at the University of Massachusetts Medical School (UMMS) have shown that knocking out a gene important for messenger RNA (mRNA) translation in neurons restores memory deficits and reduces behavioral symptoms in a mouse model of a prevalent human neurological disease. These results, published today in Nature Medicine, suggest that the prime cause of the Fragile X syndrome may be a translational imbalance that results in elevated protein production in the brain. Restoration of this balance may be necessary for normal neurological function.
"Biology works in strange ways," said Joel Richter, PhD, professor of molecular medicine at UMMS and senior author on the study. "We corrected one genetic mutation with another, which in effect showed that two wrongs make a right. Mutations in each gene result in impaired brain function, but in our studies, we found that mutations in both genes result in normal brain function. This sounds counter-intuitive, but in this case that seems to be what has happened."
Fragile X syndrome, the most common form of inherited mental retardation and the most frequent single-gene cause of autism, is a genetic condition resulting from a CGG repeat expansion in the DNA sequence of the Fragile X (Fmr1) gene required for normal neurological development. People with Fragile X suffer from intellectual disability as well as behavioral and learning challenges. Depending on the length of the CGG repeat, intellectual disabilities can range from mild to severe.
While scientists have identified the genetic mutation that causes Fragile X, on a molecular level they still don't know much about how the disease works or what precisely goes wrong in the brain as a result. What is known is that the Fmr1 gene codes for the Fragile X protein (FMRP). This protein probably has several functions throughout the neuron but its main activity is to repress the translation of as many as 1,000 different mRNAs. By doing this, FMRP controls synaptic plasticity and higher brain function. Mice without the Fragile X gene, for instance, have a 15 to 20 percent overall elevation in neural protein production. It is thought that the inability to repress mRNA translation and the resulting increase in neural proteins may somehow hamper normal synaptic function in patients with Fragile X. But because FMRP binds so many mRNAs, and some proteins become more elevated than others, parsing which mRNA or combination of mRNAs is responsible for Fragile X pathology is a daunting task.
From Frog Egg to Fragile X
For years, Dr. Richter had been studying how translation, the process in which cellular ribosomes create proteins, went from dormant to active in frog eggs. He discovered the key gene controlling this process, the RNA binding protein CPEB. In 1998, Richter found the CPEB protein in the rodent brain where it played an important role in regulating how synapses talk to each other. At this point, his work began to move from exploring the role of CPEB in the developmental biology of the frog to how the CPEB protein impacted learning and memory. A serendipitous research symposium with colleagues at Cold Spring Harbor got him thinking about CPEB and Fragile X syndrome.
"Here I was, an outsider, a molecular biologist who had worked for years with frog eggs, in the same room with neurobiologists and neurologists, when they started talking about Fragile X syndrome and translational activity," said Richter. "It got me thinking that the CPEB protein might be a path to restoring the translational imbalance they were discussing."
Richter knew that CPEB stimulated translation and that FMRP repressed it. He also knew that animal models lacking the CPEB protein had memory deficits and that both proteins bound to many of the same mRNAs – the overlap may be as higher as 33 percent. The thought was that by taking away a protein that stimulated translation might counterbalance the loss of the repressor FMRP protein, thereby restoring translational homeostasis in the brain and normal neurological function.
"It was one of those kind of goofy 'what if' sort of things," said Richter.
To test his hypothesis, Richter developed a double knockout mouse model that lacked both the FMRP gene that caused Fragile X and the CPEB gene. When they began measuring for Fragile X pathologies what they found was almost too good to be true.
"We measured a host of factors, biochemical, morphological, electrophysiological and behavioral phenotypes," said Richter. "And we kept finding the same thing. By knocking out both the FMRP and CPEB genes we were able to restore levels of protein synthesis to normal and corrected the disease characteristics of the Fragile X mice, making them almost indistinguishable from wild type mice."
Most importantly, tests to evaluate short-term memory in the double knockout mice also showed normal results with no indications of Fragile X pathology. This suggested an experiment to test whether CPEB might be a potential therapeutic target for Fragile X to benefit patients. Richter and colleagues took adult Fragile X mice and injected a lentivirus that expresses a small RNA to knock down CPEB in the hippocampus, which is a brain region that is important for short-term memory. Subsequent tests showed improved short-term memory in these mice, indicating that at least this one characteristic of Fragile X syndrome, which is generally thought to be a developmental disorder, can be reversed in adults.
"People with Fragile X make too much protein," said Richter. "By using CPEB to recalibrate the cellular machinery that makes protein we've shown that tamping down this process has a profoundly good impact on mouse models with Fragile X. It may be that a similar approach could be beneficial for kids with this disease."
The next step for Richter and colleagues is to determine which, of the more than 300 mRNAs that both CPEB and FMRP bind to, contribute to Fragile X syndrome and how. They'll also begin looking at small molecules and other avenues that, like the ablation of the CPEB protein, might be able to slow down the synthesis of protein. "There are several small molecules that we know affect the translational apparatus," Richter said. "Some cross the blood/brain barrier, some are toxic, and some are not. We'd like to investigate those."
"This is another, great example of how basic science translates to human disease," said Richter. "If we had started out looking at the human brain, not knowing about the CPEB protein and its role in translational activity, we wouldn't have had any idea where to start or what to look for. But because we started out in the frog, where things are much easier to see, and because more often than not these processes are conserved, we've learned something new and totally unexpected that may have a profound impact on human disease."
###
About the University of Massachusetts Medical School
The University of Massachusetts Medical School (UMMS), one of five campuses of the University system, is comprised of the School of Medicine, the Graduate School of Biomedical Sciences, the Graduate School of Nursing, a thriving research enterprise and an innovative public service initiative, Commonwealth Medicine. Its mission is to advance the health of the people of the Commonwealth through pioneering education, research, public service and health care delivery with its clinical partner, UMass Memorial Health Care. In doing so, it has built a reputation as a world-class research institution and as a leader in primary care education. The Medical School attracts more than $240 million annually in research funding, placing it among the top 50 medical schools in the nation. In 2006, UMMS's Craig C. Mello, PhD, Howard Hughes Medical Institute Investigator and the Blais University Chair in Molecular Medicine, was awarded the Nobel Prize in Physiology or Medicine, along with colleague Andrew Z. Fire, PhD, of Stanford University, for their discoveries related to RNA interference (RNAi). The 2013 opening of the Albert Sherman Center ushered in a new era of biomedical research and education on campus. Designed to maximize collaboration across fields, the Sherman Center is home to scientists pursuing novel research in emerging scientific fields with the goal of translating new discoveries into innovative therapies for human diseases.
2 genetic wrongs make a biochemical right
Genetic mutation found to restore translational balance in mice
2013-10-21
ELSE PRESS RELEASES FROM THIS DATE:
Flu virus wipes out immune system's first responders to establish infection
2013-10-21
Flu virus wipes out immune system's first responders to establish infection
CAMBRIDGE, Mass. (October 20, 2013) -- Revealing influenza's truly insidious nature, Whitehead Institute scientists have discovered that the virus is able to infect its ...
Blood stem cells age at the unexpected flip of a molecular switch
2013-10-21
Blood stem cells age at the unexpected flip of a molecular switch
Scientists report in Nature they have found a novel and unexpected molecular switch that could become a key to slowing some of the ravages of getting older as it prompts blood ...
Mixing nanoparticles to make multifunctional materials
2013-10-21
Mixing nanoparticles to make multifunctional materials
Standardized technique opens remarkable opportunities for 'mix and match' materials fabrication
UPTON, NY-Scientists at the U.S. Department of Energy's Brookhaven National Laboratory have developed ...
Rats! Humans and rodents process their mistakes
2013-10-21
Rats! Humans and rodents process their mistakes
Study finds parallels in neural processing of 'adaptive control'
PROVIDENCE, R.I. [Brown University] — People and rats may think alike when they've made a mistake and are trying to adjust their thinking.
That's ...
Cells' 'molecular muscles' help them sense and respond to their environments
2013-10-21
Cells' 'molecular muscles' help them sense and respond to their environments
Johns Hopkins researchers used suction to learn that individual "molecular muscles" within cells respond to different types of force, a finding that may explain how cells "feel" the ...
Inherited gene variation tied to high-risk pediatric leukemia and greater risk of relapse
2013-10-21
Inherited gene variation tied to high-risk pediatric leukemia and greater risk of relapse
Study led by St. Jude Children's Research Hospital finds an inherited gene variation -- more common among Hispanic Americans -- is tied to increased risk of developing ...
Clean living is a luxury wild animals can't afford, study suggests
2013-10-21
Clean living is a luxury wild animals can't afford, study suggests
Domestic animals will choose to steer clear of dirt – but their wild cousins can't be so picky and may be at increased risk of disease as a result.
A study of wild mice has shown that ...
Large-scale deep re-sequencing reveals cucumber's evolutionary enigma
2013-10-21
Large-scale deep re-sequencing reveals cucumber's evolutionary enigma
The latest study was published online in Nature Genetics
October 20, 2013, Shenzhen, China - In a collaborative study published online today in Nature Genetics, researchers from the Genome Centre of Chinese Academy of Agricultural ...
Neuron 'claws' in the brain enable flies to distinguish 1 scent from another
2013-10-21
Neuron 'claws' in the brain enable flies to distinguish 1 scent from another
Cold Spring Harbor, NY -- Think of the smell of an orange, a lemon, and a grapefruit. Each has strong acidic notes mixed with sweetness. And yet each fresh, bright scent is ...
Delayed gratification hurts climate change cooperation
2013-10-21
Delayed gratification hurts climate change cooperation
Time is a huge impediment when it comes to working together to halt the effects of climate change, new research suggests.
A study published today in the journal Nature Climate Change reveals that ...
LAST 30 PRESS RELEASES:
Sugar-coated nanotherapy dramatically improves neuron survival in Alzheimer’s model
Uncovering compounds that tame the heat of chili peppers
Astronomers take a second look at twin star systems
Updated version of the "How Equitable Is It?" tool for assessing equity in scholarly communication models
McGill researchers lead project to reform youth mental health care in Canada
ESMT Berlin research shows private ownership boosts hospital performance
The risk of death or complications from broken heart syndrome was high from 2016 to 2020
Does adapting to a warmer climate have drawbacks?
Team develops digital lab for data- and robot-driven materials science
Got data? Breastfeeding device measures babies’ milk intake in real time
Novel technology enables better understanding of complex biological samples
Autistic people communicate just as effectively as others, study finds
Alaska: Ancient cave sediments provide new climate clues
Adult-onset type 1 diabetes increases risk of cardiovascular disease and death
Onion-like nanoparticles found in aircraft exhaust
Chimpanzees use medicinal leaves to perform first aid
New marine-biodegradable polymer decomposes by 92% in one year, rivals nylon in strength
Manitoba Museum and ROM palaeontologists discover 506-million-year-old predator
Not all orangutan mothers raise their infants the same way
CT scanning helps reveal path from rotten fish to fossil
Physical activity + organized sports participation may ward off childhood mental ill health
Long working hours may alter brain structure, preliminary findings suggest
Lower taxes on Heated Tobacco Products are subsidizing tobacco industry – new research
Recognition from colleagues helps employees cope with bad work experiences
First-in-human study of once-daily oral treatment for obesity that mimics metabolic effects of gastric bypass without surgery
Rural preschoolers more likely to be living with overweight and abdominal obesity, and spend more time on screens, than their urban counterparts
Half of popular TikToks about “food noise” mention medications, mainly weight-loss drugs, to manage intrusive thoughts about food
Global survey reveals high disconnect between perceptions of obesity among people living with the disease and their doctors
Study reveals distinct mechanisms of action of tirzepatide and semaglutide
Mount Sinai Health System to honor Dennis S. Charney, MD, Dean of the Icahn School of Medicine at Mount Sinai, for 18 years of leadership and service at annual Crystal Party
[Press-News.org] 2 genetic wrongs make a biochemical rightGenetic mutation found to restore translational balance in mice